hematologically malignant diseases
Conditions
Interventions
None listed
Sponsors
Japanese Pediatric Leukemia/Lymphoma Study Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age between 0 to 20 years old One who will receive allogeneic stem cell transplantation One who is enrolled in CHM-14 study One who has written agreement or ascent by oneself or from the guardians for this study
Exclusion criteria
Exclusion criteria: nothing particular
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Risk factors of DIC and its frequency | — |
Secondary
| Measure | Time frame |
|---|---|
| The relation of transplantation-related mortality and morbidity with DIC The rate of improvement of DIC one week after the onset of DIC and its poor prognostic factors | — |
Countries
Japan
Contacts
Public ContactMasayuki Nagasawa
Musashino Red Cross Hospital Department of Pediatrics
Outcome results
None listed